What is AccendoWave?
AccendoWave is at the forefront of developing non-pharmaceutical solutions for pain management. The company's innovative technology suite includes a tablet, EEG headband, and proprietary software, all integrated into its Active Discomfort Management system. This system has shown significant efficacy, with 83% of patients experiencing reduced discomfort in clinical trials. AccendoWave primarily targets healthcare providers, such as hospitals, that are increasingly mandated to offer alternative pain relief options beyond pharmaceuticals. Their application of AI in health technology has garnered recognition, including a quarterfinalist position in the UCSF Health Awards.
How much funding has AccendoWave raised?
AccendoWave has raised a total of $12K across 1 funding round:
Debt
$12K
Debt (2021): $12K with participation from PPP
Key Investors in AccendoWave
PPP
Public-Private Partnership
What's next for AccendoWave?
With its Series A/B growth stage funding, AccendoWave is poised for significant expansion. The recent capital injection is expected to accelerate the development and deployment of its Active Discomfort Management system. This strategic investment will likely enable AccendoWave to scale its operations, enhance its technological capabilities, and broaden its market reach within the healthcare provider segment. The company's focus on AI-driven, non-pharmaceutical pain relief aligns with a growing trend in healthcare, suggesting a strong trajectory for future growth and market penetration.
See full AccendoWave company page
